FDA Enforcement Follow-Through Could Thin Out Violators
This article was originally published in The Tan Sheet
Executive Summary
FDA's emphasis on follow-through in its revamped enforcement strategy may help weed out bad actors from legitimate industry
You may also be interested in...
FDA Policy Power Challenged In House Questions On Untitled Letters
Oversight and Investigations Subcommittee Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours. The Energy and Commerce Committee examines whether FDA use of untitled letters is “fair, effective and efficient in gaining compliance,” he says.
FDA Policy Power Challenged In House Questions On Untitled Letters
Oversight and Investigations Subcommittee Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours. The Energy and Commerce Committee examines whether FDA use of untitled letters is “fair, effective and efficient in gaining compliance,” he says.
Tainted Supplement Recalls Prompt Call For Tighter Regulations – Letter
A research letter says that tainted supplements accounted for more than half of class I recalls from 2004-2012, and the researchers argue for stricter regulation. Industry points to a steep drop-off after 2010, and call for stronger enforcement of existing regulations.